Subsequent to the issuance of our Form 10-K for the year ended December 31, 2019, management identified certain individually immaterial errors aggregating to $6.3 million related to governmental rebate accruals associated with Makena sales from 2016 through 2019.

From 2016 through 2019, we understated our GTN adjustments for governmental rebates and the related accrual for a certain state program. We concluded that the errors were not material to any prior annual or interim period; however, we determined that correcting the aggregate error would be material to the three and six months ended June 30, 2020. As a result, we have revised our historical financial statements to properly reflect GTN adjustments and the related accrual in the appropriate periods.

The effect of the corrections to our consolidated balance sheet for the years ended December 31, 2019 and 2018 were as follows (in thousands):



	December 31, 2019
	As reported			Adjustment			As adjusted
Accrued expenses	177,079			6,303			183,382
Accumulated deficit	$	(1,008,898	)	$	(6,303	)	$	(1,015,201	)



	December 31, 2018
	As reported			Adjustment			As adjusted
Accrued expenses	129,537			5,098			134,635
Accumulated deficit	$	(542,442	)	$	(5,098	)	$	(547,540	)

The effect of the corrections to our consolidated statements of operations for the years ended December 31, 2019, 2018 and 2017 are as follows (in thousands, except per share amounts):



	Year Ended December 31, 2019
	As reported			Adjustment			As adjusted
Product sales, net	$	311,190		$	(1,205	)	$	309,985
Total revenues	327,751			(1,205		)	326,546
Income tax (benefit) expense	(47		)	—			(47		)
Net loss from continuing operations	(466,456		)	(1,205		)	(467,661		)
Net loss	$	(466,456	)	$	(1,205	)	$	(467,661	)

Basic and diluted net loss per share	$	(13.71	)	$	(0.03	)	$	(13.74	)



	Year Ended December 31, 2018
	As reported			Adjustment			As adjusted
Product sales, net	$	473,852		$	(1,954	)	$	471,898
Total revenues	474,002			(1,954		)	472,048
Income tax (benefit) expense	39,654			782			40,436
Net loss from continuing operations	(169,339		)	(2,736		)	(172,075		)
Net loss	$	(65,761	)	$	(2,736	)	$	(68,497	)

Basic and diluted net loss per share	$	(1.91	)	$	(0.08	)	$	(1.99	)



	Year Ended December 31, 2017
	As reported			Adjustment			As adjusted
Product sales, net	$	495,645		$	(1,802	)	$	493,843
Total revenues	495,769			(1,802		)	493,967
Income tax (benefit) expense	(175,254		)	(267		)	(175,521		)
Net loss from continuing operations	(205,153		)	(1,535		)	(206,688		)
Net loss	$	(199,228	)	$	(1,535	)	$	(200,763	)

Basic and diluted net loss per share	$	(5.71	)	$	(0.04	)	$	(5.75	)

The consolidated statements of other comprehensive loss for the years ended December 31, 2019, 2018 and 2017 have been revised to include the changes to “net loss” summarized above.

The consolidated statements of stockholders’ equity for the years ended December 31, 2019, 2018 and 2017 have been revised to include the changes to “net loss” summarized above as well as an increase of $0.8 million to the beginning “accumulated deficit” as of January 1, 2017, representing the accumulated error through that date.

The impact on our consolidated statements of cash flows for the years ended December 31, 2019, 2018 and 2017, was limited to the offsetting corrections between “net loss” and changes in “accounts payable and accrued expenses” and “deferred income taxes” presented within “net cash used in operating activities” in each year, as summarized in the above tables.